Observational Study
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Apr 27, 2023; 15(4): 687-697
Published online Apr 27, 2023. doi: 10.4240/wjgs.v15.i4.687
Efficacy and safety analysis of transarterial chemoembolization and transarterial radioembolization in advanced hepatocellular carcinoma descending hepatectomy
Rui Feng, De-Xin Cheng, Tao Song, Long Chen, Kai-Ping Lu
Rui Feng, De-Xin Cheng, Department of Interventional Medicine, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou 310000, Zhejiang Province, China
Tao Song, Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou 310000, Zhejiang Province, China
Long Chen, Department of Radiotherapy, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou 310000, Zhejiang Province, China
Kai-Ping Lu, Department of Vascular Surgery, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, Hangzhou 310000, Zhejiang Province, China
Author contributions: Feng R and Lu KP designed the study and wrote the manuscript; Feng R and Cheng DX analyzed the data; Song T and Chen L were responsible for revising the paper; all authors have read and agreed to the published version of the manuscript.
Institutional review board statement: The study was approved by Ethics Committee of the Third Hospital of Zhejiang Provincial People’s Hospital.
Informed consent statement: All study participants provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kai-Ping Lu, MM, Associate Chief Physician, Department of Vascular Surgery, Zhejiang Provincial People’s Hospital, People’s Hospital of Hangzhou Medical College, No. 158 Shangtang Road, Gongshu District, Hangzhou 310000, Zhejiang Province, China. lukaiping158@126.com
Received: January 17, 2023
Peer-review started: January 17, 2023
First decision: March 1, 2023
Revised: March 9, 2023
Accepted: March 23, 2023
Article in press: March 23, 2023
Published online: April 27, 2023
Processing time: 95 Days and 20.1 Hours
Core Tip

Core Tip: The transarterial radioembolization (TARE) technique treats hepatocellular carcinoma (HCC) by perfusing radionuclide microspheres into the HCC lesion through the hepatic arterial route and releasing ionizing radiation through the radionuclide carried by the microspheres. With the development of materials science, stable radionuclide microspheres have been widely applied in clinical practice. On this basis, we found that the combined effect of transarterial chemoembolization and TARE techniques could increase the inactivation of HCC lesions, expand the scope of tumor necrosis, increase postoperative survival rate, and improve the life quality of patients. It has high clinical value in the descending treatment of patients with HCC.